Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

Divi’s Laboratories shares surged to a fresh 52-week high after strong Q2 FY27 results and positive broker commentary. Net profit rose 64% year-on-year to ₹1,127 crore, while revenue grew 35% to ₹3,676 crore. Brokerages highlighted growth potential in custom synthesis and peptides.
Read the full story on Mint Opens livemint.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by Mint, shown with a link to the original. The full story, photo and reporting belong to Mint.











